Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study

(2011) David M. Brown et al.   OPHTHALMOLOGY

The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema

(2011) Diana V. Do et al.   OPHTHALMOLOGY

The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing

(2011) Jeffrey S. Heier et al.   OPHTHALMOLOGY

Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study

(2011) Peter A. Campochiaro et al.   OPHTHALMOLOGY

The RESTORE Study

(2011) Paul Mitchell et al.   OPHTHALMOLOGY

Histopathology of Neovascular Tissue From Eyes With Proliferative Diabetic Retinopathy After Intravitreal Bevacizumab Injection

(2010) Ri-Ichiro Kohno et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Clinical Factors Related to Recurrence of Anterior Segment Neovascularization After Treatment Including Intravitreal Bevacizumab

(2010) Yoshiaki Saito et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2

(2010) Prema Abraham et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Angiographic Changes in Iris and Iridocorneal Angle Neovascularization After Intravitreal Bevacizumab Injection

(2010) Shingo Ishibashi   ARCHIVES OF OPHTHALMOLOGY

Fluorescein Angiography of Recurrent Retinopathy of Prematurity After Initial Intravitreous Bevacizumab Treatment

(2010) Quan V. Hoang   ARCHIVES OF OPHTHALMOLOGY

Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study

(2010) T. R. Friberg et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

(2010) P. Massin et al.   DIABETES CARE

Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage

(2010) Hossein Nazari et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels

(2010) Joo Yong Lee et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Combined Intravitreal Bevacizumab and Trabeculectomy With Mitomycin C Versus Trabeculectomy With Mitomycin C Alone for Neovascular Glaucoma

(2010) Yuji Takihara et al.   JOURNAL OF GLAUCOMA

Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion

(2010) Peter A. Campochiaro et al.   OPHTHALMOLOGY

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2010) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

(2010) David M. Brown et al.   OPHTHALMOLOGY

Effects and Complications of Bevacizumab Use in Patients with Retinopathy of Prematurity: A Multicenter Study in Taiwan

(2010) Wei-Chi Wu et al.   OPHTHALMOLOGY

Preoperative Intravitreal Bevacizumab Use as an Adjuvant to Diabetic Vitrectomy: Histopathologic Findings and Clinical Implications

(2010) Hazem A. El-Sabagh et al.   OPHTHALMOLOGY

HISTOLOGY OF FIBROVASCULAR MEMBRANES OF PROLIFERATIVE DIABETIC RETINOPATHY AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB

(2010) TOSHIAKI KUBOTA et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

VITRECTOMY AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR RETINAL DETACHMENT IN RETINOPATHY OF PREMATURITY

(2010) ANDRÉS KYCHENTHAL et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Repeated intravitreal bevacizumab (Avastin®) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation

(2009) Gerald Schmidinger et al.   ACTA OPHTHALMOLOGICA

Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma

(2009) Yoshiaki Saito et al.   ACTA OPHTHALMOLOGICA

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

(2009) Geeta A. Lalwani et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of Prematurity

(2009) Jonathan A. Micieli et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Topical Bevacizumab in the Treatment of Corneal Neovascularization

(2009) Mohammad H. Dastjerdi   ARCHIVES OF OPHTHALMOLOGY

Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab

(2009) T Kubota et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study)

(2009) D da R Lucena et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Avastin use in high risk corneal transplantation

(2009) Petja Ivanova Vassileva et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin®) eye drops against corneal neovascularization

(2009) Yanyan Koenig et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Intravitreal Bevacizumab for Neovascular Glaucoma

(2009) Shahin Yazdani et al.   JOURNAL OF GLAUCOMA

Vitreous Levels of Erythropoietin and Vascular Endothelial Growth Factor in Eyes with Retinopathy of Prematurity

(2009) Tatsuhiko Sato et al.   OPHTHALMOLOGY

The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The Twenty-five-Year Incidence of Macular Edema in Persons with Type 1 Diabetes

(2009) Ronald Klein et al.   OPHTHALMOLOGY

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2009) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Intravitreal Bevacizumab for Prevention of Early Postvitrectomy Hemorrhage in Diabetic PatientsA Randomized Clinical Trial

(2009) Hamid Ahmadieh et al.   OPHTHALMOLOGY

ANTIANGIOGENIC THERAPY WITH INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY

(2009) HUGO QUIROZ-MERCADO et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

OFF-LABEL USE OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR SALVAGE TREATMENT IN PROGRESSIVE THRESHOLD RETINOPATHY OF PREMATURITY

(2009) GEETA A. LALWANI et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

CONCENTRATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN AQUEOUS HUMOR OF EYES WITH ADVANCED RETINOPATHY OF PREMATURITY BEFORE AND AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB

(2009) NORIE ITO NONOBE et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

(2008) Carl D. Regillo et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion

(2008) Richard F. Spaide et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Intravitreous Bevacizumab as Anti–Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Morphologic Study

(2008) Lingkun Kong   ARCHIVES OF OPHTHALMOLOGY

Immunohistochemical localisation of intravitreally injected bevacizumab in the anterior chamber angle, iris and ciliary body of the primate eye

(2008) S Peters et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study

(2008) S Kusaka et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity

(2008) Shigeru Honda et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)

(2008) Stanislao Rizzo et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy

(2008) Siamak Moradian et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator

(2008) Peter A Campochiaro et al.   MOLECULAR THERAPY

Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein Occlusions

(2008) Dante J. Pieramici et al.   OPHTHALMOLOGY

Intravitreal Bevacizumab to Treat Iris Neovascularization and Neovascular Glaucoma Secondary to Ischemic Retinal Diseases in 41 Consecutive Cases

(2008) Taku Wakabayashi et al.   OPHTHALMOLOGY

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

(2008) David M. Brown et al.   OPHTHALMOLOGY

The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy

(2008) Esther J. Kuiper et al.   PLoS One

Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

(2008) Magali Saint-Geniez et al.   PLoS One

INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) FOR TREATMENT OF STAGE 3 RETINOPATHY OF PREMATURITY IN ZONE I OR POSTERIOR ZONE II

(2008) HELEN A. MINTZ-HITTNER et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES